Showing 5581-5600 of 8668 for: Cochrane Systematic Reviews Back
- Oral protein‐based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis
Cochrane Systematic Reviews, 11-May-2020
Malnutrition is common in patients with chronic kidney disease (CKD) on dialysis. Oral protein-based nutritional supplements are often provided to patients whose oral intake is otherwise insufficient to meet their energy and protein needs. Evidence for th
- Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions
Cochrane Systematic Reviews, 7-Dec-2011
Oral rehydration solution (ORS) is used to treat the dehydration caused by diarrhoeal diseases, including cholera. ORS formulations with an osmolarity (a measure of solute concentration) of = 270 mOsm/L (ORS = 270) are safe and more effective than ORS for
- Oral rinses, mouthwashes and sprays for improving recovery following tonsillectomy
Cochrane Systematic Reviews, 10-Sep-2013
This is an update of a Cochrane review first published in The Cochrane Library in Issue 1, 2010 and previously updated in 2011.
- Oral steroids for adhesive capsulitis
Cochrane Systematic Reviews, 6-Nov-2008
This review is one in a series of Cochrane reviews of interventions for shoulder pain in adults.
- Oral steroids for long‐term use in cystic fibrosis
Cochrane Systematic Reviews, 9-Dec-2015
In cystic fibrosis (CF) airway obstruction and recurrent respiratory infection lead to inflammation, long-term lung damage, respiratory failure and death. Anti-inflammatory agents, e.g. oral corticosteroids are used since inflammation occurs early in dise
- Oral steroids for nasal polyps
Cochrane Systematic Reviews, 25-Apr-2016
This is an update of a Cochrane Review first published in The Cochrane Library in Issue 1, 2007.
- Oral stimulation for promoting oral feeding in preterm infants
Cochrane Systematic Reviews, 20-Sep-2016
Preterm infants (< 37 weeks' postmenstrual age) are often delayed in attaining oral feeding. Normal oral feeding is suggested as an important outcome for the timing of discharge from the hospital and can be an early indicator of neuromotor integrity and d
- Oral substitution treatment of injecting opioid users for prevention of HIV infection
Cochrane Systematic Reviews, 10-Aug-2011
Injecting drug users are vulnerable to infection with Human Immunodeficiency Virus (HIV) and other blood borne viruses as a result of collective use of injecting equipment as well as sexual behaviour
- Oral tapentadol for cancer pain
Cochrane Systematic Reviews, 25-Sep-2015
A large proportion of people with advanced cancer will experience moderate to severe pain. Tapentadol is a novel, centrally acting analgesic medicine acting at the µ-opioid receptor and inhibiting noradrenaline reuptake. The efficacy of tapentadol is stat
- Oral theophylline for chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 21-Oct-2002
Oral theophylline has, for many years, been used as a bronchodilator in patients with COPD. Despite the introduction of new drugs, and its narrow therapeutic index, theophylline is still recommended for COPD treatment.
- Oral traditional Chinese medication for adhesive small bowel obstruction
Cochrane Systematic Reviews, 10-Apr-2012
Small bowel obstruction (SBO) is one of the most common emergent complications of general surgery. Intra-abdominal adhesions are the leading cause of SBO. Because surgery can induce new adhesions, non-operative management is preferred in the absence of si
- Oral treatments for fungal infections of the skin of the foot
Cochrane Systematic Reviews, 17-Oct-2012
About 15% of the world population have fungal infections of the feet (tinea pedis or athlete's foot). There are many clinical presentations of tinea pedis, and most commonly, tinea pedis is seen between the toes (interdigital) and on the soles, heels, and
- Oral vaccines for preventing cholera
Cochrane Systematic Reviews, 3-Aug-2011
Cholera is a cause of acute watery diarrhoea which can cause dehydration and death if not adequately treated. It usually occurs in epidemics, and is associated with poverty and poor sanitation. Effective, cheap, and easy to administer vaccines could help
- Oral versus inhaled antibiotics for bronchiectasis
Cochrane Systematic Reviews, 27-Mar-2018
Bronchiectasis is a chronic inflammatory disease characterised by a recurrent cycle of respiratory bacterial infections associated with cough, sputum production and impaired quality of life. Antibiotics are the main therapeutic option for managing bronchi
- Oral versus injectable ovulation induction agents for unexplained subfertility
Cochrane Systematic Reviews, 22-Jul-2002
Oral (anti-oestrogens) and injectable (gonadotrophins) ovulation induction agents have been used to increase the number of eggs produced by a woman per cycle in treatment for unexplained subfertility. It is unclear whether there are significant advantages
- Oral versus intra‐vaginal imidazole and triazole anti‐fungal treatment of uncomplicated vulvovaginal candidiasis (thrush)
Cochrane Systematic Reviews, 24-Aug-2020
Anti-fungals are available for oral and intra-vaginal treatment of uncomplicated vulvovaginal candidiasis.
- Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
Cochrane Systematic Reviews, 21-Sep-2016
Fever occurring in a neutropenic patient remains a common life-threatening complication of cancer chemotherapy. The common practice is to admit the patient to hospital and treat him or her empirically with intravenous broad-spectrum antibiotics. Oral ther
- Oral versus intravenous fluoropyrimidines for colorectal cancer
Cochrane Systematic Reviews, 28-Jul-2017
Patients prefer oral to intravenous (IV) palliative chemotherapy, provided that oral therapy is not less effective. We compared the efficacy and safety of oral and IV fluoropyrimidines for treatment of colorectal cancer (CRC).
- Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children
Cochrane Systematic Reviews, 19-Jul-2006
Dehydration associated with gastroenteritis is a serious complication. Oral rehydration is an effective and inexpensive treatment, but some physicians prefer intravenous methods.
- Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
Cochrane Systematic Reviews, 12-Dec-2012
This is an updated Cochrane review of the previous version published (Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD006921. DOI: 10.1002/14651858.CD006921.pub2).
